←Back to Expert Scholars
Translational Medicine / 转化医学Precision Oncology Platforms, Genomics
Christopher Mason
PhD
🏢Weill Cornell Medicine🌐USA
Professor of Physiology and Biophysics
65
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Christopher Mason leads genomics platform development at Weill Cornell, including long-read sequencing and metagenomic platforms applied to cancer. He directs translational studies integrating microbiome and tumor genomics. His work expands the technological foundation of precision oncology.
Share:
🧪Research Fields 研究领域
genomics platforms
metagenomics
long-read sequencing
cancer genome biology
AI in oncology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Christopher Mason 的研究动态
Follow Christopher Mason's research updates
留下邮箱，当我们发布与 Christopher Mason（Weill Cornell Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment